Research and Developments

Page 5 of 18« First...34567...10...Last »

July 19, 2015

Trash-Collecting Cells May Accelerate Retinitis Pigmentosa

Posted in: Latest News, Research and Developments

NIH research points to microglia as potential therapeutic target in retinitis pigmentosa Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study
read more »

June 24, 2015

Orcam Now Available in the U.S.

Posted in: Latest News, Research and Developments

In November 2013, an article appeared here about OrCam, a camera-based system which allows the visually impaired to both read and identify objects with a point of a finger. The device is a small camera connected by a thin cable to a portable computer in the wearer’s pocket. The system clips on to the wearer’s
read more »

June 19, 2015

Cheaper Substitute for Lucentis Developed in India

Posted in: Latest News, Research and Developments

Intas Pharmaceuticals, a company based in India, has launched RAZUMAB™, an anti-VEGF drug that is “biosimilar” to Lucentis. This means that RAZUMAB has a synthesized chemical structure that can substitute for, but not duplicate, Lucentis. To make biosimilarity possible, scientists must show that the new product is highly similar and have no significant differences from
read more »

May 20, 2015

Summary of Research and Development – 2015

Posted in: Latest News, Research and Developments

by Dan Roberts (Also available in audiovisual format) INTRODUCTION This is my 10th annual summary of leading research and developments that have occurred during the past 12 months in the field of blindness and low vision. For more details about any of the reports, sources are provided. Many studies and clinical trials are moving ever
read more »

May 14, 2015

MD Support’s LowViz Guide Offers Gift of Sight

Posted in: Latest News, Research and Developments

For four days, Bill DeMaio could see through walls. And that’s really saying something, considering that he has no eyesight. Until May 10, 2015, Bill could find his way around an unfamiliar building only by either asking people for directions or hoping to find Braille signs. But then, on the first day of the 2015
read more »

May 7, 2015

L-DOPA May Slow Development of AMD

Posted in: Latest News, Research and Developments

The color (pigmentation) of the retina, or lack thereof, is thought to play a role in the development of age-related macular degeneration (AMD). The substance that provides pigmentation is melanin, and a precursor to the pigment melanin is called L-DOPA. Since L-DOPA converts into dopamine in the brain, it has been used as a treatment
read more »

May 1, 2015

Stem Cell Therapy Shows Positive Results In Asian Patients

Posted in: Latest News, Research and Developments

Ocata Therapeutics, Inc. (now owned by Acucela) has announced positive results in four Asian patients who were treated with the company’s proprietary RPE stem cells. These new data support previously reported positive long-term safety and signs of visual improvement, as reported here in October 2014. The Korean study, published online in Stem Cell Reports, features
read more »

February 10, 2015

Notal Vision Device Shows 94% Success at Early Detection of Age-Related Macular Degeneration

Posted in: Latest News, Research and Developments

A National Eye Institute study has reported an impressive success rate at early detection of wet (neovascular) age-related macular degeneration (AMD). The study compared two groups of dry AMD patients and compared the proportion within each group for patients presenting with 20/40 acuity or better when their wet AMD was detected. An experimental group used
read more »

January 21, 2015

Does Calcium Cause AMD?

Posted in: Latest News, Research and Developments

New research may be misconstrued by Dan Roberts A recent press release from the University of Maryland School of Medicine has found that tiny spherules of calcium phosphate known as hydroxyapatite, or HAP) may be an important “triggering factor” for age-related macular degeneration (AMD). The report appeared in the latest issue of the Proceedings of the National Academy of Sciences.
read more »

November 19, 2014

FHL-1 Protein Deficiency May Cause AMD

Posted in: Latest News, Research and Developments

A protein released by the complement factor H (CFH) gene has been thought to be responsible for protecting the retina from inflammation leading to age-related macular degeneration (AMD). Scientists from the University of Manchester have, however, now discovered that the protein factor H is not the main regulator of immunity. Instead, it is a different
read more »

Page 5 of 18« First...34567...10...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann